Low-dose (0.2 mg/day) and standard-dose (0.4 mg/day) tamsulosin were studied in a randomized controlled trial of 75 outpatients with distal ureteroliths in Thailand. Group 1 (n = 25; control) received oral sodium diclofenac 50 mg twice a day for 10 days; group 2 (n = 25) received oral sodium diclofenac 50 mg twice a day for 10 days, with oral tamsulosin 0.2 mg once a day up to 28 days; and group 3 (n = 25) received oral sodium diclofenac 50 mg twice a day for 10 days, with oral tamsulosin 0.4 mg once a day up to 28 days. For groups 1, 2 and 3, respectively, the expulsion rates were 4%, 40% and 68% (significantly different for group 1 vs group 2, and for group 1 vs group 3) and mean expulsion times were 23.00, 9.30 and 10.76 days. Both doses of tamsulosin increased stone expulsion rate and decreased expulsion time in comparison with the control, and have been shown to be safe and effective in Asian patients.
DellabellaMMilaneseGMuzzonigroG: Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol2003; 170: 2202–2205.
2.
TroxelSAJonesAWMagliolaL: Physiologic effect of nifedipine and tamsulosin on contractility of distal ureter. J Endourol2006; 20: 565–568.
3.
SigalaSDellabellaMMilaneseG: Evidence for the presence of α1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn2005; 24: 142–148.
4.
ParkCHChangHSOhBR: Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A nonblind multicenter Korean study. Clin Drug Invest2004; 24: 41–47.
5.
LiNGChenSYangXH: Efficacy of low-dose tamsulosin in Chinese patients with symptomatic benign prostatic hyperplasia. Clin Drug Invest2003; 23: 781–787.
6.
LeeE: Comparison of tamsulosin and finasteride for lower urinary tract symptoms associated with benign prostatic hyperplasia in Korean patients. J Int Med Res2003; 30: 584–590.
7.
MillerOFKaneCJ: Time to stone passage for observed ureteral calculi: A guide for patient education. J Urol1999; 162: 688–691.
8.
IbrahimAIShettySDAwadRM: Prognostic factors in the conservative treatment of ureteral stones. Br J Urol1991; 67: 358–361.
9.
HubnerWAIrbyPStollerML: Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol1993; 24: 172–176.
10.
PorpigliaFGhignoneGFioriC: Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol2004; 172: 568–571.
11.
PorpigliaFVaccinoDBilliaM: Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureteral stones: Single drug or association?Eur Urol2006; 50: 339–344.
12.
DellabellaMMilaneseGMuzzonigroG: Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol2005; 174: 167–172.
13.
DellabellaMMilaneseGMuzzonigroG: Medical-expulsive therapy for distal ureterolithiasis: Randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. Urology2005; 66: 712–715.
14.
KupeliBIrkilataLGurocakS: Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?Urology2004; 64: 1111–1115.
15.
GravinaGLCostaAMRonchiP: Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology2005; 66: 24–28.
16.
ResimSEkerbicerHCCiftciA: Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology2005; 66: 945–948.
17.
YilmazEBatislamEBasarMM: The comparison and efficacy of 3 different α1-adrenergic blockers for distal ureteral stones. J Urol2005; 173: 2010–2012.
